SCHEMBL892676

SCHEMBL892676

CCCCCCCCCCCCNC1CC(C)(C)NC(C)(C)C1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 2/20 0.51
GNAO1 P09471 2/20 0.51
GNAI1 P63096 2/20 0.51
SLC2A1 P11166 1/20 0.48
GBA1 P04062 6/20 0.44
S1PR4 O95977 2/20 0.44
S1PR1 P21453 2/20 0.44
S1PR3 Q99500 2/20 0.44
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
S1PR5 Q9H228 1/20 0.39
RECQL P46063 1/20 0.37
FUCA1 P04066 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17409734 1.00 GNAI3 (0.51) GNAI3GNAO1GNAI1SLC2A1GBA1
SCHEMBL990185 1.00 GNAI3 (0.51) GNAI3GNAO1GNAI1SLC2A1GBA1
SCHEMBL10633005 1.00 GNAI3 (0.51) GNAI3GNAO1GNAI1SLC2A1GBA1
SCHEMBL3140456 1.00 GNAI3 (0.51) GNAI3GNAO1GNAI1SLC2A1GBA1
SCHEMBL11026100 1.00 GNAI3 (0.51) GNAI3GNAO1GNAI1SLC2A1GBA1
SCHEMBL11212575 1.00 GNAI3 (0.51) GNAI3GNAO1GNAI1SLC2A1GBA1
Ammonia Solution, Strong SCHEMBL7733882 0.98 GNAI3 (0.50) GNAI3GNAO1GNAI1SLC2A1GBA1
SCHEMBL5250714 0.98 GNAI3 (0.49) GNAI3GNAO1GNAI1SLC2A1GBA1
SCHEMBL3675581 0.96 SLC2A1 (0.48) GNAI3GNAO1GNAI1SLC2A1GBA1
1,2-Dibromoethane SCHEMBL27826246 0.93 GNAI3 (0.46) GNAI3GNAO1GNAI1SLC2A1GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0172413-B1 PROCESS FOR PRODUCING PIPERIDINE DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-06-16 EP claimed
WO-2025070288-A1 RESIN COMPOSITION, MOLDED BODY, AND OPTICAL COMPONENT 三井化学株式会社 2025-04-03 WO disclosed
US-8765740-B2 Cytotoxic benzodiazepine derivatives IMMUNOGEN, INC. (US) 2014-07-01 US disclosed
CN-103122076-A Resin composition and molded article produced from the composition MITSUI CHEMICALS INC 2013-05-29 CN disclosed
CN-101522813-B Resin composition and molded article obtained from the composition MITSU CHEMICALS INC 2013-01-30 CN disclosed
US-20120083557-A1 STERICALLY HINDERED AMINE STABILIZERS BASF SE (DE) 2012-04-05 US disclosed
US-20100074083-A1 RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION MITSUI CHEMICALS, INC. (JP) 2010-03-25 US disclosed
US-20100074083-A1 RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION MITSUI CHEMICALS, INC. (JP) 2010-03-25 US disclosed
US-20100074083-A1 RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION MITSUI CHEMICALS, INC. (JP) 2010-03-25 US disclosed
CN-101522813-A Resin composition and molded article obtained from the composition MITSUI CHEMICALS INC (JP) 2009-09-02 CN disclosed
EP-0427672-A1 Polymer stabilizers containing both hindered amine and hydroxylamine moieties CIBA-GEIGY AG (CH) 1991-05-15 EP disclosed
US-4920228-A N,N-disubstituted, α-(3,5-dialkyl-4-hydroxyphenyl)-α,α-disubstituted acetamides and composition stabilized therewith THE B. F. GOODRICH COMPANY (US) 1990-04-24 US disclosed
EP-0284800-A1 N-(substituted piperidinyl)-alpha-(3,5-dialkyl-4-hydroxyphenyl)-alpha', alpha''-dialkyl acetamides THE B.F. GOODRICH COMPANY (US) 1988-10-05 EP disclosed
EP-0112690-B1 TRIS(PIPERIDYLAMINOTRIAZYLAMINO) COMPOUNDS, THEIR PREPARATION AND THEIR USE AS POLYMER STABILIZERS SANKYO COMPANY LIMITED (JP) 1987-04-29 EP disclosed
EP-0172413-A2 Process for producing piperidine derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-02-26 EP disclosed
US-4533688-A AGAINST EFFECTS OF LIGHT SANKYO COMPANY LIMITED (JP) 1985-08-06 US disclosed
EP-0112690-A2 Tris(piperidylaminotriazylamino) compounds, their preparation and their use as polymer stabilizers SANKYO COMPANY LIMITED (JP) 1984-07-04 EP disclosed
US-4376836-A PHOTOSTABILITY HOECHST AKTIENGESELLSCHAFT (DE) 1983-03-15 US disclosed
US-4348524-A LIGHT STABILIZERS FOR POLYPROPYLENE CIBA-GEIGY CORPORATION (US) 1982-09-07 US disclosed
EP-0044499-A1 Triazinylaminotriazines, their preparation, their use in stabilising synthetic polymers and products realised with them HOECHST AKTIENGESELLSCHAFT (DE) 1982-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100074083-A1 RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION SEM1, WDR5, WDR1 GNAI3 3433/4885GNAO1 2769/4885GNAI1 3082/4885
US-20120083557-A1 STERICALLY HINDERED AMINE STABILIZERS AAAS, H1-5, H1-2 GNAI3 3971/4885GNAO1 3079/4885GNAI1 3574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.